Clinical trials
Asthma clinical trials
A condition where the airways narrow and swell, making breathing difficult. We’re tracking 390 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07359846RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma in adults and teens
This trial tests an add-on treatment called GB-0895 for people with severe asthma that is not well controlled with current medications. It aims to see if adding this drug can reduce asthma attacks and improve lung function.
Bakersfield, CaliforniaAges 12–80 - NCT07345572Recruiting
Early time-restricted eating for mild asthma
This study explores whether eating only during certain hours of the day (early time-restricted eating) can improve health and quality of life for adults with mild controlled asthma, compared to adults without asthma. Participants will follow a specific eating schedule for a period, and researchers will monitor outcomes.
Leicester, EnglandAges 18–65 - NCT07556159Recruiting
Asthma Disease Patterns and Outcomes in Everyday Care
This study observes how asthma is managed and controlled in routine clinical practice. Researchers will collect information about your asthma symptoms, treatments, and outcomes over time to better understand real-world asthma management.
Chandler, ArizonaAges 6 years+ - NCT06307665RecruitingPhase 3
Asthma study for teens comparing two inhalers
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Anchorage, AlaskaAges 12–17 - NCT06191315Enrolling by invitationPhase 3
Dupilumab for asthma and wheezing in young children
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
Phoenix, ArizonaAges 2–5 - NCT06223828RecruitingPhase 2/Phase 3
Azithromycin for Children with Severe Asthma in the ICU
This trial tests whether adding the antibiotic azithromycin to standard asthma treatments helps children with severe asthma in the pediatric intensive care unit (PICU) recover faster. It is for children ages 3 to 17 who are already receiving strong asthma medicines and steroids.
St. Petersburg, FloridaAges 3–17 - NCT06471257RecruitingPhase 3
Study of PT027 vs PT007 in Chinese Adults with Asthma
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
BaotouAges 18 years+ - NCT05999032Recruiting
Puerto Rico Asthma Integrated Response Program for children
This study tests a program to help children aged 2 to 12 with asthma that is not well controlled. The program provides support and resources to improve asthma management at home.
Providence, Rhode IslandAges 2–12 - NCT04743791RecruitingPhase 4
Dupilumab study for clearing mucus in moderate to severe asthma
This study tests whether dupilumab improves how well mucus is cleared from the airways in adults with moderate to severe asthma. It may help find better ways to reduce mucus-related breathing problems in people with a specific asthma type.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07245368RecruitingPhase 1/Phase 2
Testing a new asthma drug in healthy people and those with asthma
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
Botany, New South WalesAges 18–65 - NCT06623981Recruiting
Treating maternal depression in an urban asthma clinic
This study tests whether treating depression in Black mothers of children with asthma can improve both the mother's mood and the child's asthma. It offers support for mothers who are feeling down and may help their child's asthma get better.
Washington D.C., District of ColumbiaAges Any age - NCT06552013Recruiting
Asthma study for kids in Georgetown and South Park
This study tests whether reducing air pollution can help control asthma in children living in the Duwamish Valley. Kids with poorly controlled asthma who live in specified Seattle neighborhoods may benefit from cleaner air.
Seattle, WashingtonAges 6–17 - NCT06015256Recruiting
Natural killer cells in severe asthma patients
This study looks at immune cells called natural killer cells in people with severe asthma. Researchers want to see how these cells are different in people whose asthma is well-controlled, not well-controlled, or flaring up, compared to healthy volunteers without asthma.
MarseilleAges 18 years+ - NCT05004714Recruiting
Head Start asthma program study for staff and caregivers
This study helps test an approach to improve asthma care for children in Head Start. You may be able to help by participating as a Head Start staff member or caregiver and allowing audio recording of your input.
District Heights, MarylandAges 18 years+ - NCT04912596Recruiting
Tested albuterol inhaler compared to a standard inhaler for mild asthma
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
AhmedabadAges 20–65 - NCT05008965RecruitingPhase 2
Study drug for allergic asthma in adults
This Phase 2 trial tests whether FB825 can improve symptoms and safety in adults with moderate-to-severe allergic asthma. It is mainly for people whose asthma is not well controlled despite regular inhaler treatment.
Kaohsiung CityAges 18–75 - NCT04395937Recruiting
Study of gentle aerobic exercise to improve severe asthma control
This trial studies whether a lower-intensity aerobic exercise program (not maximal effort) can improve asthma symptoms and control. It is meant for adults with asthma who are still not well controlled despite current inhaler treatments.
Liège, LiegeAges 18–65 - NCT05761028RecruitingPhase 2/Phase 3
CM310 for moderate to severe asthma despite current inhalers
This study tests CM310 to see if it can improve asthma in people with moderate to severe asthma who are still having uncontrolled symptoms and severe flare-ups despite regular inhaler treatment. You may be eligible if your lung function and asthma control tests fit the study limits and you’ve had a recent severe exacerbation.
Beijing, BeijinAges 12–75 - NCT07665892RecruitingPhase 1
Testing a new asthma drug in adults
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
Glendale, ArizonaAges 18–55 - NCT07143747Recruiting
Lung Imaging Study for Mild Asthma
This study uses special MRI and CT scans to take very detailed pictures of the lungs in people with mild asthma. The goal is to learn more about how asthma affects the lungs, which could help develop better treatments.
London, OntarioAges 17–35 - NCT06239844Recruiting
Asthma guidance for non-English speaking families
This study helps families who speak a language other than English manage their child's asthma better. It connects you with a guide who supports your family in navigating asthma care and improving your child's breathing.
Aurora, ColoradoAges 4–89 - NCT07488897RecruitingPhase 1/Phase 2
Testing RIG-101 in healthy adults and adults with asthma
This trial tests an experimental medicine called RIG-101 in healthy adults and adults with asthma. The goal is to see if it can safely prevent or reduce asthma worsening after exposure to a common cold virus (rhinovirus).
LondonAges 18–65 - NCT05667701RecruitingPhase 2
Soy supplement for babies at high risk of asthma
This Phase 2 study tests whether daily soy isoflavones can lower the chance of asthma or wheezing problems in babies who are at high risk. You would join because your baby has risk factors (family history and certain genetics) and receives the study soy product.
Chicago, IllinoisAges 2 months–1 year - NCT07168473RecruitingPhase 3
A study of DW1807 for year-round allergies and asthma
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
SeoulAges 19 years+
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma?
- Yes. Clin2 currently lists 390 recruiting asthma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.